All In Biotech

Drug Trial Radar · NCT04269902

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Randomized, Phase III Study of Early Intervention With Venetoclax and Obinutuzumab Versus Delayed Therapy With Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 247 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

247

Planned (sponsor's estimate)

Start

Mar 2, 2021

Primary completion

Oct 1, 2028

Study completion Oct 1, 2028

Sponsor

Sponsor type
NIH
First posted
Feb 17, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Immunotherapy with monoclonal antibodies, such as obinutuzumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with the venetoclax and obinutuzumab early (before patients have symptoms) may have better outcomes for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma compared to starting treatment with the venetoclax and obinutuzumab after patients show symptoms.

Conditions

  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma

Interventions

  • Biospecimen CollectionProcedure

    Undergo collection of blood samples

  • Bone Marrow AspirationProcedure

    Undergo bone marrow aspiration

  • Bone Marrow BiopsyProcedure

    Undergo bone marrow biopsy

  • Computed TomographyProcedure

    Undergo CT

  • ObinutuzumabBiological

    Given IV

  • Questionnaire AdministrationOther

    Ancillary studies

  • VenetoclaxDrug

    Given PO

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall survival (OS)Time frame: From the day of registration on study until death from any cause with observations censored on the day of last contact for participants not known to have died, assessed up to 10 years
  2. Functional Assessment of Cancer Therapy (FACT)-Leukemia total scoreTime frame: At 2 years

Locations

633 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama · Active not recruiting

  • Anchorage Associates in Radiation Medicine

    Anchorage, Alaska · Suspended

  • Anchorage Radiation Therapy Center

    Anchorage, Alaska · Suspended

  • Alaska Breast Care and Surgery LLC

    Anchorage, Alaska · Suspended

  • Alaska Oncology and Hematology LLC

    Anchorage, Alaska · Suspended

  • Alaska Women's Cancer Care

    Anchorage, Alaska · Suspended

  • Anchorage Oncology Centre

    Anchorage, Alaska · Suspended

  • Katmai Oncology Group

    Anchorage, Alaska · Suspended

  • Providence Alaska Medical Center

    Anchorage, Alaska · Suspended

  • Fairbanks Memorial Hospital

    Fairbanks, Alaska · Suspended

  • Cancer Center at Saint Joseph's

    Phoenix, Arizona · Active not recruiting

  • Banner University Medical Center - Tucson

    Tucson, Arizona · Recruiting

  • University of Arizona Cancer Center-North Campus

    Tucson, Arizona · Recruiting

  • Mercy Hospital Fort Smith

    Fort Smith, Arkansas · Suspended

  • CHI Saint Vincent Cancer Center Hot Springs

    Hot Springs, Arkansas · Suspended

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro

    Jonesboro, Arkansas · Recruiting

  • Kaiser Permanente-Anaheim

    Anaheim, California · Recruiting

  • Mission Hope Medical Oncology - Arroyo Grande

    Arroyo Grande, California · Active not recruiting

  • Kaiser Permanente-Baldwin Park

    Baldwin Park, California · Recruiting

  • Kaiser Permanente-Bellflower

    Bellflower, California · Recruiting

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center

    Burbank, California · Suspended

  • Marshall Cancer Center

    Cameron Park, California · Recruiting

  • Mercy Cancer Center - Carmichael

    Carmichael, California · Active not recruiting

  • Mercy San Juan Medical Center

    Carmichael, California · Active not recruiting

  • Enloe Medical Center

    Chico, California · Recruiting

  • UC Irvine Health Cancer Center-Newport

    Costa Mesa, California · Recruiting

  • City of Hope Comprehensive Cancer Center

    Duarte, California · Recruiting

  • Mercy Cancer Center - Elk Grove

    Elk Grove, California · Active not recruiting

  • Kaiser Permanente-Fontana

    Fontana, California · Recruiting

  • Kaiser Permanente South Bay

    Harbor City, California · Recruiting

  • City of Hope Seacliff

    Huntington Beach, California · Recruiting

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care

    Irvine, California · Recruiting

  • City of Hope at Irvine Lennar

    Irvine, California · Recruiting

  • Kaiser Permanente-Irvine

    Irvine, California · Recruiting

  • UCI Health Laguna Hills

    Laguna Hills, California · Recruiting

  • City of Hope Antelope Valley

    Lancaster, California · Recruiting

  • City of Hope at Long Beach Elm

    Long Beach, California · Recruiting

  • Tibor Rubin VA Medical Center

    Long Beach, California · Active not recruiting

  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California · Recruiting

  • Kaiser Permanente West Los Angeles

    Los Angeles, California · Recruiting

Showing 40 of 633 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.